[1. Osungbade KO, Ige OK. Public Health Perspectives of Preeclampsia in Developing Countries: Implication for Health System Strengthening. J Pregnancy. 2011; 2011: 481095.]Search in Google Scholar
[2. Madazli R, Bulut B, Tuten A, Aydin B, Demirayak G, Kucur M. First-trimester maternal serum metastin, placental growth factor and chitotriosidase levels in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):146-9. DOI: 10.1016/j.ejogrb.2012.06.01610.1016/j.ejogrb.2012.06.01622770630]Search in Google Scholar
[3. Vitoratos N, Hassiakos D, Iavazzo C. Molecular mechanisms of preeclampsia. J Pregnancy. 2012; 2012:298343. DOI: 10.1155/2012/145487 DOI: 10.1155/2012/29834310.1155/2012/145487336855222690336]Search in Google Scholar
[4. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2008 Nov;32(6):732-9. DOI: 10.1002/uog.624410.1002/uog.624418956425]Search in Google Scholar
[5. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. J Matern Fetal Neonatal Med. 2005 Jul;18(1):9-16. DOI: 10.1080/1476705050020249310.1080/1476705050020249316105786]Search in Google Scholar
[6. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia. N Engl J Med. 2006 Sep 7;355(10):992-1005. DOI: 10.1056/NEJMoa05535210.1056/NEJMoa05535216957146]Search in Google Scholar
[7. Fialova L, Malbohan IM. Pregnancy-associated plasma protein A (PAPP-A): theoretical and clinical aspects. Bratisl Lek Listy. 2002;103(6):194-205.]Search in Google Scholar
[8. Youssef A, Righetti F, Morano D, Rizzo N, Farina A. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia. Prenat Diagn. 2011 Dec;31(12):1141-6.10.1002/pd.284822034048]Search in Google Scholar
[9. Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L, et al. First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012 Jun; 33(6): 495-501. DOI: 10.1016/j.placenta.2012.03.00310.1016/j.placenta.2012.03.00322459245]Search in Google Scholar
[10. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Gonçalves LF, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol. 2007 Apr;196(4):326.e1-13. DOI: 10.1016/j.ajog.2006.11.00210.1016/j.ajog.2006.11.002219073117403407]Search in Google Scholar
[11. Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33(1):8-15. DOI: 10.1159/00034126410.1159/00034126422906914]Search in Google Scholar
[12. Laresqoiti-Servitje E. A leading role for the immune system in the pathopysiology of preeclampsia. J Leukoc Biol 2013 Aug; 94 (2):247-57. DOI: 10.1189/jlb.111260310.1189/jlb.111260323633414]Search in Google Scholar
[13. Cali U, Cavkaytar S, Sirvan L, Danisman N. Placental apoptosis in preeclampsia, intrauterine growth retardation and HELLP syndrome: an immunohistochemical study with caspase-3 and bcl-2. Clin Exp Obstet Gynecol. 2013; 40 (1): 45-8.]Search in Google Scholar
[14. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu RW, Panesar NS, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4748-53. DOI: 10.1073/pnas.063745010010.1073/pnas.063745010015362712644709]Search in Google Scholar
[15. Tsui NB, Wong CS, Chow KC, Lo ES, Cheng YK. Investigation of biological factors influencing the placental mRNA profile in maternal plasma. Prenat. Diagn. 2014, 34, 251–258. DOI: 10.1002/pd.430010.1002/pd.430024352757]Search in Google Scholar
[16. Farina A. The role of RNAs and microRNAs in non-invasive prenatal diagnosis. J Clin Med 2014; 3: 440-452. DOI: 10.3390/jcm302044010.3390/jcm3020440444968026237384]Search in Google Scholar
[17. Okazaki S, Sekizawa A, Purwosunu Y, Iwasaki M, Farina A, Okai T. Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood. J Med Genet. 2006 Sep;43(9):e47. DOI: 10.1136/jmg.2005.04063410.1136/jmg.2005.040634256458016950818]Search in Google Scholar
[18. Heung MM, Jin S, Tsui NB, Ding C, Leung TY, Lau TK, et al. Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood. PLoS One. 2009 Jun 10; 4(6): e5858. DOI: 10.1371/journal.pone.000585810.1371/journal.pone.0005858269065519516908]Search in Google Scholar
[19. Sekizawa A, Purwosunu Y, Farina A, Shimizu H, Nakamura M, Wibowo N, et al. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15–20 weeks of gestation. BJOG 2010, 117, 557–564. DOI: 10.1111/j.1471-0528.2010.02491.x10.1111/j.1471-0528.2010.02491.x20121832]Search in Google Scholar
[20. Farina A, Zucchini C, Sekizawa A, Purwosunu Y, de Sanctis P, Santarsiero G, et al. Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10–14 weeks. Am. J. Obstet. Gynecol. 2010, 203, e1–e7. DOI: 10.1016/j. ajog.2010.07.043]Search in Google Scholar
[21. Available at https://www.nice.org.uk/guidance/cg107.]Search in Google Scholar
[22. Purwosunu Y, Sekizawa A, Okazaki S, Farina A, Wibowo N, Nakamura M, et al. Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma. Am. J. Obstet. Gynecol. 2009, 200, doi:10.1016/j.ajog.2008.11.035. DOI: 10.1016/j.ajog.2008.11.03510.1016/j.ajog.2008.11.03519217595]Search in Google Scholar
[23. Anton L, Olarerin-George AO, Schwartz N, Srinivas S, Bastek J, Hogenesch JB, et al. miR-210 inhibits trophoblast invasion and is a serum biomarker for preeclampsia. Am J Pathol. 2013 Nov;183(5):1437-45. DOI: 10.1016/j.ajpath.2013.07.02110.1016/j.ajpath.2013.07.021381452124035613]Search in Google Scholar